comparemela.com

Keynote 426 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Advanced kidney cancer treatment landscapeKidney cancerRenal cell carcinomaKidney cancer studiesKidney cancer trialsClear trialKeynote 426Checkmate 9er

Dr Zhang on the Selection of Immunotherapy-Based Regimens in Metastatic RCC

Tian Zhang, MD, MHS, discusses the selection of first-line immunotherapy-based treatments for patients with metastatic renal cell carcinoma.

Department of internal medicineHaroldc simmons comprehensive cancer centerUt southwestern medical centerTian zhangInternal medicineComprehensive cancer centerMedical centerUt southwestern haroldc simmons comprehensive cancer centerOnclive tvGenitourinary cancerRenal cell carcinomaVegf tkisClear studyKeynote 426

Front Line Trials in Advanced RCC

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

Benjamin garmezyPedro barataRenal cell carcinomaClear trialCheckmate 9erKeynote 426Checkmate 214Io tkis

vimarsana © 2020. All Rights Reserved.